Very-Late Onset Multiple Acyl-Coenzyme A Dehydrogenase Deficiency Associated With Sertraline Use: A Case Report
This case supports the recent findings that sertraline can be associated with very-late-onset MADD. Neurologists should maintain a high index of suspicion for MADD in sertraline-treated patients with unexplained weakness because prompt initiation of riboflavin is crucial for strength recovery.
Authors
- Marcus Vinícius Pinto (ORCID: https://orcid.org/0000-0002-9890-6657)
- Sofia Rael (ORCID: https://orcid.org/0000-0003-0541-9022)
- Teerin Liewluck (ORCID: https://orcid.org/0000-0002-0212-5697)
- Thapat Wannarong (ORCID: https://orcid.org/0000-0003-1839-1903)
- Rafid Mustafa (ORCID: https://orcid.org/0000-0003-2827-0507)
- Margherita Milone (ORCID: https://orcid.org/0000-0002-4338-9007)
- Camilo Bermudez (ORCID: https://orcid.org/0000-0002-9461-5094)
- Scott D.Z. Eggers (ORCID: https://orcid.org/0000-0001-8786-1054)
- Allison R. Valerius (ORCID: https://orcid.org/0000-0002-1708-6205)
Institutions
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- Journal of Clinical Neuromuscular Disease
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1097/cnd.0000000000000528
- Citations
- 1
- Primary Topic
- Metabolism and Genetic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.32